Screener
Syndax Pharmaceuticals SNDX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-197154
FAQ
- What is Syndax Pharmaceuticals's asset turnover?
- Syndax Pharmaceuticals (SNDX) reported asset turnover of 0.4× in Q1 2026.
- How has Syndax Pharmaceuticals's asset turnover changed year-over-year?
- Syndax Pharmaceuticals's asset turnover increased by 428.6% year-over-year, from 0.1× to 0.4×.
- What is the long-term trend for Syndax Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's asset turnover has grown at a 101.4% compound annual growth rate (CAGR), from 0× to 0.3×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Syndax Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude